Medications Targeting Underlying Mechanisms
For patients: read the interpreting-treatment-responses section and the phenotype-targeted-treatment-pathways section to understand how a medicationβs benefit or null response informs your treatment plan. This chapter interprets medication responses β it does not prescribe; any medication decision belongs to your prescriber.
For caregivers: read the interpreting-treatment-responses section to track what a medication is and is not doing, and the medication-sensitivity-phenotypes section if the patient reacts unusually to drugs.
For clinicians: read the per-system medication sections (immune, antiviral, mitochondrial, autonomic, mast-cell, CNS-stimulant) to match a drug class to the suspected underlying mechanism, guided by the phenotype-targeted-treatment-pathways section.
For researchers: the mechanism-directed drug sections and the medication-sensitivity-phenotypes hypotheses identify which mechanisms lack validated pharmacological probes.
1 Contents
- Immune-Modulating Medications
- Antiviral Medications
- Mitochondrial Support
- Herbal Anti-Inflammatory Agents
- Neuroprotective and Cognitive Enhancers
- CNS Stimulants and Wakefulness-Promoting Agents
- Interpreting Treatment Responses
- Phenotype-Targeted Treatment Pathways
- Autonomic Medications
- H2 Receptor Antagonists
- Antihistamine Up-Dosing in MCAS
- Medication Sensitivity Phenotypes
- Atypical Antipsychotics: Metabolic Considerations in ME/CFS